A systematic review of neuroprotective therapies for visual acuity preservation in retinitis pigmentosa.
- 2026-04
- Systematic Review · n = 1,364
- BMJ open ophthalmology 11(2)
- Sam Sherratt-Mayhew
- Max Bisp
- Sanna Waheed
- Charles Page
- Wing Sze Vangie Koo
- Shashwat Deep
- PubMed: 42297463
- DOI: 10.1136/bmjophth-2026-002771
- High evidence
- Clinical
Lycium barbarum, which was associated with modest BCVA improvement in a single phase II trial with a very low GRADE certainty of evidence.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes